UNII 593YOG76RN

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Unique Ingredient Identifier 593YOG76RN is listed as a ingredient substance

• RN: 10049-21-5
• NCIT: C61947
• RXCUI: 221125
• PUBCHEM: 516949
• MF: Na.H2O.H2O4P
• INCHI KEY: BBMHARZCALWXSL-UHFFFAOYSA-M
• SMILES: O.[Na+].OP(O)([O-])=O

Dosage Forms

UNII 593YOG76RN SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE is commonly included in medications in the following forms.

Route	Dosage Form	Potency
IM - IV	INJECTABLE	0.18 %
IM - IV	INJECTION	0.5 %
IM - IV	POWDER	1.56 %
IM - IV	POWDER, FOR INJECTION SOLUTION	0.18 %
INTRA-ARTICULAR	INJECTABLE	0.34 %
INTRALESIONAL	INJECTABLE	0.68 %
INTRAMUSCULAR	INJECTABLE	0.68 %W/V
INTRAMUSCULAR	INJECTION	5 mg/1mL
INTRAMUSCULAR	INJECTION	0.15 %W/V
INTRAMUSCULAR	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	NA
INTRAMUSCULAR	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH	0.14 %
INTRAMUSCULAR	SUSPENSION, INJECTION	0.38 %W/V
INTRASYNOVIAL	INJECTABLE	0.68 %
INTRAVASCULAR	INJECTION	NA
INTRAVENOUS	INJECTABLE	1.8 mg/mL
INTRAVENOUS	INJECTION	6.21 %
INTRAVENOUS	INJECTION	5 mg/1mL
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION	0.05 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.05 %
INTRAVENOUS	SOLUTION, INJECTION	0.54 %
INTRAVESICAL	SOLUTION	NA
INTRAVITREAL	INJECTABLE	0.86 %
IV(INFUSION)	INJECTION	0.5 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION	1.36 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.02 %
OPHTHALMIC	DROPS	0.041 %
OPHTHALMIC	SOLUTION	0.72 %
OPHTHALMIC	SOLUTION, DROPS	0.72 %
OPHTHALMIC	SOLUTION/DROPS	1.3 %
OPHTHALMIC	SUSPENSION	0.54 %
ORAL	CAPSULE	600 MG
ORAL	ORAL SOLUTION DOSAGE FORM	30 mg/5mL
ORAL	SOLUTION	258 MG/20ML
ORAL	SUSPENSION	37.5 MG/5ML
ORAL	SYRUP	20.6 MG/5ML
ORAL	TABLET	31.72 MG
ORAL	TABLET, DELAYED ACTION, ENTERIC COATED	35 MG
ORAL	TABLET, FILM COATED	0.11 MG
SUBCUTANEOUS	INJECTABLE	0.036 %
SUBCUTANEOUS	INJECTION	0.12 %
SUBCUTANEOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.064 %
TOPICAL	CREAM	0.3 %W/W
TOPICAL	EMULSION, CREAM	0.3 %W/W
TOPICAL	LOTION	0.27 %W/W
TOPICAL	LOTION, AUGMENTED	0.15 %W/W
TOPICAL	SOLUTION	0.46 %W/V
TOPICAL	SOLUTION, DROPS	0.46 %W/V
URETERAL	SOLUTION	NA